Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

26,588 signal articles · 279 in last 24h · 127,601 total before filter · latest 35m ago
279last 24h
1238last 7d
199● bullish (7d)
121● bearish (7d)
206publishers
AllMacro244Earnings484M&A84Regulatory22Product11Analyst16
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Bloomberg17d agoneutral
Bessent’s Whatever-It-Takes Yen Pledge Masks Limited Firepower

(Bloomberg) -- Treasury Secretary Scott Bessent’s suggestion of a no-limits approach toward helping Japan rescue the yen risks getting called out by market participants flagging his limited firepower to do the job.Most Read from BloombergChina Unleashes $28 Trillion Capital Markets to Challenge US in AIStocks Churn as Hormuz Standoff Spurs Rally in Oil: Markets WrapIran Shakes Up Security Team After Saying Oman Deal ‘Very Close’GameStop’s Ryan Cohen Weighs Pulling $56 Billion EBay OfferTrump Amp

1 Stock Under $10 to Target This Week and 2 We Ignore
StockStory17d agoneutral
1 Stock Under $10 to Target This Week and 2 We Ignore

Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as many have questionable fundamentals.

140-year-old Dividend King eyes bold update to unlock new growth
TheStreet17d agoneutral
140-year-old Dividend King eyes bold update to unlock new growth

Most 140-year-old companies are coasting. Johnson & Johnson (JNJ) is restructuring. And that's the part of the J&J story that rarely gets enough attention. When people think of this company, they think of dividend checks and baby powder. A steady, predictable blue-chip that you hold ...

Hims & Hers Health (NYSE:HIMS) Exceeds Q2 CY2026 Expectations But Stock Drops
StockStory17d agobearish
Hims & Hers Health (NYSE:HIMS) Exceeds Q2 CY2026 Expectations But Stock Drops

Telehealth company Hims & Hers Health (NYSE:HIMS) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 38.2% year on year to $753.2 million. On top of that, next quarter’s revenue guidance ($890 million at the midpoint) was surprisingly good and 12.4% above what analysts were expecting. Its GAAP loss of $0.37 per share was significantly below analysts’ consensus estimates.

Oil Surges With No Hormuz Deal in Sight
The Wall Street Journal17d agobullish
Oil Surges With No Hormuz Deal in Sight

Oil prices jumped after negotiations over the Strait of Hormuz turned south once again. Over the weekend, a top Iranian official laid out a series of tough demands for opening the Strait, and the United Arab Emirates said Iran launched a missile attack on one of its ships. Nvidia reached a mammoth financing deal with leading Wall Street firms.

The ETFs Most Exposed to the 2026 Chip Supply Chain Crisis — Winners and Losers
etf.com17d agoneutral
The ETFs Most Exposed to the 2026 Chip Supply Chain Crisis — Winners and Losers

<p>High-bandwidth memory is sold out for all of 2026. SK Hynix has warned the shortage could last past 2030. Automakers are cutting production of budget models, and PC and smartphone prices are set to rise 10-20% by year-end. The chip supply chain crisis is the defining market story of 2026 and it is reshaping which ETFs win and which get squeezed. Here are the funds most exposed, on both sides of the trade.</p>

Meta announces $1B fund for communities near its data centers
Yahoo Finance Video17d agoneutralVIDEO
Meta announces $1B fund for communities near its data centers

Yahoo Finance Tech Editor Dan Howley analyzes Meta (META) CEO Mark Zuckerberg's vision for open-source "personal superintelligence," his criticism of rival AI labs, and Meta's $1 billion initiative to support communities hosting its data centers.